Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites.

<h4>Background</h4>A malaria vaccine could be an important addition to current control strategies. We report the safety and vaccine efficacy (VE) of the RTS,S/AS01 vaccine during 18 mo following vaccination at 11 African sites with varying malaria transmission.<h4>Methods and findi...

Full description

Bibliographic Details
Main Author: RTS,S Clinical Trials Partnership
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-07-01
Series:PLoS Medicine
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25072396/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25072396/?tool=EBI

Similar Items